GSK's wholesaler margin policy under fire

Published: 2007-12-31 06:58:00

Updated: 2007-12-31 06:58:00

A local group of drug wholesalers criticized the recent reduction of wholesaler margin by GlaxoSmithKline (GSK), calling for the company's perspective posture to boost a win-win strategy.

The Pharmaceutical Contribution Association argued on December 27 that GSK should reconsider its margin is...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK